Skip to main content
. 2021 Oct 7;21:251. doi: 10.1186/s12906-021-03428-6

Table 2.

Demographic and baseline characteristics

KGT group (n = 16) Placebo group (n = 14) p-value*
Demographics
Age 70.2 (7.6) 70.1 (6.4) 0.986
Sex (Male) 10 (62.5%) 7 (50%) 0.491
Educational level 12.2 (3.6) 12.3 (4.7) 0.967
Clinical characteristics
SNSB-D 176.00 (24.76) 173.79 (32.86) 0.835
Attention 9.5 (2.3) 9.3 (1.3) 0.783
Language and related function 23.6 (2.3) 22.1 (3.3) 0.232
Visuospatial function 32.94 (2.82) 33.18 (3.05) 0.732
Memory 57.88 (17.76) 57.39 (17.97) 0.942
Frontal/executive function 52.1 (9.2) 51.8 (12.8) 0.946
Other indices
CDR-SB 1.50 (1.00–2.00) 1.50 (0.88–2.50) 0.793
CDR-GS (0.5) 16 (100%) 14 (100%)
GDS (3) 16 (100%) 14 (100%)
K-MMSE 28.5 (26.3–29.0) 26.0 (24.8–28.3) 0.067
Barthel-ADL 20 20
K-IADL 1.0 (1.0–2.0) 1.0 (1.0–1.3) 0.510
SGDS 4.0 (1.3–10.8) 2.5 (1.8–9.0) 0.645

KGT, Kami-guibi-tang; SNSB-D, Seoul Neuropsychological Screening Battery for dementia; CDR-SB, Clinical Dementia Rating-Sum of Boxes; CDR-GS, Clinical Dementia Rating-Global Score; GDS, Global Deterioration Scale; K-MMSE, Korean Mini Mental State Examination; SGDS, Short version-Geriatric Depression Scale; K-IADL, Korean-Instrumental Activities of Daily Living; Barthel-ADL, Barthel-Activities of Daily Living

Values are presented as means (standard deviations), medians (Q1–Q3), or numbers (%)

*p-values for the between-group comparison using the independent t-test or chi-square test (or Fisher’s exact test)